M.C. Berchier

Medicine · Health Sciences

14h-index632citations35works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(27), Lung Cancer Research Studies(22), Lung Cancer Diagnosis and Treatment(13), Neuroendocrine Tumor Research Advances(7), Cancer therapeutics and mechanisms(5)

Publications35 total

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Working Party
Lung Cancer·2012
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer
Annals of Oncology·2008· 26 cited
Chemotherapy improves low performance status lung cancer patients
European Respiratory Journal·2007· 28 citedOpen Access
How much can patients, with low Karnofsky performance status and advanced non-small cell lung cancer, benefit from cisplatin-based chemotherapy? A retrospective analysis of a phase III randomised trial
Journal of Clinical Oncology·2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
British Journal of Cancer·2007· 10 citedOpen Access
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
Annals of Oncology·2007· 20 citedOpen Access
European Lung Cancer Working Party Clinical Practice Guidelines. Small Cell Lung Cnacer: IV. Limited disease
Hospital chronicles/Hospital Chronicles·2007· 1 citedOpen Access
Traitement des cancers bronchiques non à petites cellules, non métastatiques et non résécables. Recommandations de pratique clinique de l'European Lung Cancer Working Party
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·2006· 1 cited
Traitement des cancers bronchiques non à petites cellules et résécables. Recommandations de pratique clinique de l'European Lung Cancer Working Party
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·2006· 5 cited
A randomised phase III trial by the ELCWP comparing sequential administration of cisplatin-based chemotherapy followed by a taxan and a cisplatin-based chemotherapy with the use of taxan as salvage treatment
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·2006
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma
Lung Cancer·2005· 25 cited
O-214 Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I — IIIa non-small cell lung cancer conducted by the European Lung Cancer working party
Lung Cancer·2003· 2 cited
Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I-IIIa non-small cell lung cancer conducted by the European Lung Cancer Working Party
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·2003· 1 cited
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
British Journal of Cancer·2001· 66 citedOpen Access
True
British Journal of Cancer·2001Open Access
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer
European Journal of Cancer·1999· 29 cited
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy
Annals of Oncology·1999· 36 citedOpen Access
Prognostic factors analysis for response to chemotherapy and survival in a prospective cohort of patients with unresectable locoregional non small cell lung cancer initially treated by induction chemotherapy
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·1999· 4 cited
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy
Lung Cancer·1998· 14 cited
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Journal of Clinical Oncology·1998· 30 cited
page 1 of 2Next →

Frequent Co-authors

V. Giner(26), Jean‐Paul Sculier(21), Marianne Paesmans(20), G. Bureau(20), O Van Cutsem(20), P. Mommen(17), Jean Klášterský(17), J Thiriaux(17), Vincent Ninane(17), J. Lecomte(14), Anna Efremidis(12), Thierry Berghmans(11), M Paesmans(10), G Dabouis(9), J.P. Sculier(9), P Libert(8), R Sergysels(8), J.J. Lafitte(8), C.G. Alexopoulos(8), Arnaud Scherpereel(8)